Stay updated on ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.

Latest updates to the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page
- Check3 days agoChange DetectedA site-wide NIH notice about updates to terminology for artificial intelligence appears above the ClinicalTrials.gov error page.SummaryDifference1%

- Check10 days agoChange DetectedThe footer’s site revision marker changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check31 days agoChange DetectedRemoved the 403 Forbidden error content from the study record page, and the page now renders with the standard ClinicalTrials.gov header and footer instead of the error screen.SummaryDifference0.5%

- Check38 days agoChange DetectedThe page now displays a 403 Forbidden error with basic header/footer content and a Home link, indicating an access issue rather than an update to study information.SummaryDifference25%

- Check59 days agoChange DetectedThe page revision tag was updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a new version of the page.SummaryDifference0.0%

Stay in the know with updates to ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.